QIAGEN's GeneReader NGS System Wins International Design Distinction
First truly end-to-end solution for next-generation sequencing receives Red Dot award
HILDEN, Germany and GERMANTOWN, Maryland, April 4, 2016 /PRNewswire/ --
QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that the GeneReader NGS System has won a 2016 Red Dot award for excellence in product design. The distinction comes in an international competition among 5,200 entries judged by design experts who evaluate products on criteria such as degree of innovation, functionality, ergonomics and integration with the environment. The GeneReader NGS System is the first complete Sample to Insight next-generation sequencing (NGS) solution designed for any laboratory to deliver actionable insights.
"Earning the Red Dot distinction is very gratifying. We developed our GeneReader NGS workflow in close collaboration with laboratories to meet the need for a simpler, more cost-effective way for clinical testing to take advantage of NGS technology and improve outcomes," said Jonathan Arnold, QIAGEN's Oncology Franchise Business Leader. "The novel design comes from working with clinical research labs to create a solution for clinical research labs. Until now, fragmented workflows and bottlenecks have hindered NGS users in this field from achieving actionable insights. The GeneReader NGS System stands out as the world's first truly end-to-end NGS workflow from primary sample to final report."
Click here for full press release
Contact:
Public Relations:
Dr. Thomas Theuringer
Director Public Relations
+49-2103-29-11826
Email: [email protected]
http://www.twitter.com/qiagen
https://www.facebook.com/QIAGEN
pr.qiagen.com
Investor Relations:
John Gilardi
Vice President Corporate Communications and Investor Relations
+49-2103-29-11711
Email: [email protected]
ir.qiagen.com
SOURCE QIAGEN N.V.
Share this article